LPL Financial’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-13,124
| Closed | -$50K | – | 3514 |
|
|
2020
Q1 | $50K | Buy |
13,124
+2,953
| +29% | +$11.3K | ﹤0.01% | 3081 |
|
|
2019
Q4 | $52K | Sell |
10,171
-408
| -4% | -$2.09K | ﹤0.01% | 3253 |
|
|
2019
Q3 | $53K | Sell |
10,579
-1,048
| -9% | -$5.25K | ﹤0.01% | 3193 |
|
|
2019
Q2 | $72K | Sell |
11,627
-473
| -4% | -$2.93K | ﹤0.01% | 3166 |
|
|
2019
Q1 | $56K | Buy |
12,100
+1,228
| +11% | +$5.68K | ﹤0.01% | 3097 |
|
|
2018
Q4 | $46K | Sell |
10,872
-1,151
| -10% | -$4.87K | ﹤0.01% | 2993 |
|
|
2018
Q3 | $75K | Sell |
12,023
-1,322
| -10% | -$8.25K | ﹤0.01% | 3130 |
|
|
2018
Q2 | $107K | Sell |
13,345
-111
| -0.8% | -$890 | ﹤0.01% | 3079 |
|
|
2018
Q1 | $100K | Buy |
13,456
+2,415
| +22% | +$17.9K | ﹤0.01% | 3060 |
|
|
2017
Q4 | $66K | Buy |
11,041
+52
| +0.5% | +$311 | ﹤0.01% | 2943 |
|
|
2017
Q3 | $81K | Buy |
+10,989
| New | +$81K | ﹤0.01% | 2779 |
|
|
2017
Q2 | – | Sell |
-14,693
| Closed | -$133K | – | 3026 |
|
|
2017
Q1 | $133K | Sell |
14,693
-358
| -2% | -$3.24K | ﹤0.01% | 2576 |
|
|
2016
Q4 | $130K | Buy |
+15,051
| New | +$130K | ﹤0.01% | 2555 |
|